Cobenfy 100 MG / 20 MG (equivalent to xanomeline tartrate 153.3 MG / trospium 18.3 MG) Oral Capsule

RxCUI: 2694991
RxNorm name: Cobenfy 100 MG / 20 MG (equivalent to xanomeline tartrate 153.3 MG / trospium 18.3 MG) Oral Capsule
Display name: Cobenfy 100 MG / 20 MG (equivalent to xanomeline tartrate 153.3 MG / trospium 18.3 MG) Oral Capsule
Full name: Cobenfy 100 MG / 20 MG (equivalent to xanomeline tartrate 153.3 MG / trospium 18.3 MG) Oral Capsule
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cobenfy	XANOMELINE AND TROSPIUM CHLORIDE	E.R. Squibb & Sons, L.L.C.	8f0e73bf-6025-44f6-ab64-0983322de0df	2026-01-16	Warnings, Adverse reactions	Exact identifier rxcui: 2694991

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
8f0e73bf-6025-44f6-ab64-0983322de0df	Cobenfy 100 MG / 20 MG (equivalent to xanomeline tartrate 153.3 MG / trospium 18.3 MG) Oral Capsule	SY	4	These highlights do not include all the information needed to use COBENFY safely and effectively. See full prescribing information for COBENFY. COBENFY™ (xanomeline and trospium chloride) capsules, for oral use Initial U.S. Approval: 2024	20260116
8f0e73bf-6025-44f6-ab64-0983322de0df	Cobenfy (trospium chloride 20 MG / xanomeline 100 MG) Oral Capsule	SY	4	These highlights do not include all the information needed to use COBENFY safely and effectively. See full prescribing information for COBENFY. COBENFY™ (xanomeline and trospium chloride) capsules, for oral use Initial U.S. Approval: 2024	20260116
8f0e73bf-6025-44f6-ab64-0983322de0df	trospium chloride 20 MG / xanomeline 100 MG Oral Capsule [Cobenfy]	SBD	4	These highlights do not include all the information needed to use COBENFY safely and effectively. See full prescribing information for COBENFY. COBENFY™ (xanomeline and trospium chloride) capsules, for oral use Initial U.S. Approval: 2024	20260116
8f0e73bf-6025-44f6-ab64-0983322de0df	COBENFY 100 MG / 20 MG Oral Capsule	PSN	4	These highlights do not include all the information needed to use COBENFY safely and effectively. See full prescribing information for COBENFY. COBENFY™ (xanomeline and trospium chloride) capsules, for oral use Initial U.S. Approval: 2024	20260116